08/28/2025
6:48 PM | Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Munshi Amit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2025
6:50 PM | Aurentz Vincent (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
| Form 3/A | |
08/28/2025
6:52 PM | Cabell Christopher (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
| Form 3/A | |
08/14/2025
7:27 PM | ADAR1 Capital Management, LLC (Filed by)
Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
| Form SCHEDULE 13G/A | |
08/14/2025
4:06 PM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/13/2025
10:17 AM | Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
Sands Capital Life Sciences Pulse Fund II, L.P. (Filed by)
| Form SCHEDULE 13G/A | |
07/15/2025
10:15 AM | Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Sands Capital Alternatives, LLC (Reporting)
Sands Capital Life Sciences Pulse Fund II, L.P. (Reporting)
SANDS FRANK M. (Reporting)
| Form 3/A | |
07/02/2025
6:55 PM | Aurentz Vincent (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
| Form 4/A | |
07/02/2025
6:56 PM | Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Iwicki Mark T (Reporting)
| Form 4/A | |
07/02/2025
7:00 PM | Cabell Christopher (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
| Form 4/A | |
07/02/2025
6:38 PM | Bellini Roberto (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for IKT and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
07/02/2025
6:40 PM | BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
6:41 PM | Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Kush Arvind (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
6:43 PM | Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Munshi Amit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
6:48 PM | Canner David (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2025
6:49 PM | Aurentz Vincent (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2025
11:15 PM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form EFFECT | |
06/20/2025
4:06 PM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/14/2025
4:29 PM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/14/2025
4:06 PM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2025
3:05 PM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form PRE 14A | |
04/14/2025
7:16 AM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2025
4:01 PM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/24/2025
7:14 AM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2025
7:16 PM | Freeman Roy Lester (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:18 PM | Bellini Roberto (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:19 PM | Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Kush Arvind (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:24 PM | Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Iwicki Mark T (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/19/2025
7:26 PM | Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Iwicki Mark T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:00 PM | BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:06 PM | BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
| Form 4/A | |
02/19/2025
7:11 PM | Canner David (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/19/2025
7:11 PM | Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Munshi Amit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/18/2025
7:09 AM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
8:04 PM | ADAR1 Capital Management, LLC (Filed by)
Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
| Form SCHEDULE 13G | |
02/14/2025
4:35 PM | ARMISTICE CAPITAL, LLC (Filed by)
Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/14/2025
2:45 PM | Fairmount Funds Management LLC (Filed by)
Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/04/2025
3:06 PM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/29/2025
3:05 PM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2025
3:05 PM | BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
3:05 PM | Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Werner Milton H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
One tiny company just cracked Google’s $19B problem (Ad) An MIT lab recently cracked a code scientists had been chasing for decades…
Turning a “miracle metal” from a $63,000 luxury… into a 90-cent mass production reality.
It’s 400x stronger than steel, conducts electricity better than copper… and just saved 379 lives in a single plane crash. One small U.S. company controls the only factory making it at scale. |
01/22/2025
3:05 PM | Freeman Roy Lester (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2025
3:05 PM | Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Lees-Rolfe Garth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2025
11:15 PM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form EFFECT | |
01/10/2025
3:37 PM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/07/2025
5:39 PM | Freeman Roy Lester (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
5:43 PM | Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Lees-Rolfe Garth (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
5:47 PM | Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Werner Milton H. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2025
5:38 PM | BERMAN DENNIS N (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/06/2025
5:06 AM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2024
11:15 PM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form EFFECT | |
12/05/2024
3:47 PM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form 424B3 | |
12/05/2024
3:50 PM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/03/2024
5:24 AM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form S-3/A | |
11/18/2024
3:49 PM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/14/2024
7:30 AM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2024
3:07 PM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form PRE 14A | |
10/28/2024
4:26 PM | Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
SP IKT Holdings LLC (Filed by)
| Form SC 13G | |
10/28/2024
3:00 PM | Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
Soleus Private Equity Fund III, L.P. (Filed by)
| Form SC 13G | |
10/25/2024
4:52 PM | Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Sands Capital Life Sciences Pulse Fund II, L.P. (Reporting)
Sands Capital Ventures, LLC (Reporting)
SANDS FRANK M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/25/2024
4:50 PM | Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
Sands Capital Life Sciences Pulse Fund II, L.P. (Filed by)
| Form SC 13G | |
10/23/2024
6:58 PM | Canner David (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
6:35 PM | Bellini Roberto (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2024
6:36 PM | Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Munshi Amit (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2024
6:38 PM | Canner David (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2024
6:40 PM | Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Kush Arvind (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/23/2024
6:43 PM | Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Munshi Amit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
6:49 PM | Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
Kush Arvind (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/23/2024
6:53 PM | Bellini Roberto (Reporting)
Inhibikase Therapeutics (Issuer)
Inhibikase Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/22/2024
3:15 PM | Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
10/21/2024
8:13 PM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
6:00 PM | Fairmount Funds Management LLC (Filed by)
Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
| Form SC 13G | |
10/17/2024
3:05 PM | COMMODORE CAPITAL LP (Filed by)
Inhibikase Therapeutics (Subject)
Inhibikase Therapeutics, Inc. (Subject)
| Form SC 13G | |
10/10/2024
4:31 PM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/09/2024
7:40 AM | Inhibikase Therapeutics (Filer)
Inhibikase Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
